TSH receptor autoantibodies

Autoimmunity Reviews

Volumn 9, Issue 2, 2009, Pages 113-116

  Michalek, Krzysztof ^a   Morshed, Syed A ^a   Latif, Rauf ^a   Davies, Terry F ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antibody epitopes; Graves' disease; Signal transduction; Thyroid autoimmunity; TSH receptor; TSHR antibodies

Indexed keywords

AUTOANTIBODY; CYCLIC AMP; EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROTROPIN RECEPTOR AUTOANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; AUTOIMMUNE THYROIDITIS; GRAVES DISEASE; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERTHYROIDISM; IMMUNOPATHOLOGY; NONHUMAN; PROTEIN CONFORMATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; CELL GROWTH PROCESSES; EPITOPES, B-LYMPHOCYTE; GRAVES DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 70350572832     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.03.012     Document Type: Review

References (35)

1. Davies T., Marians R., and Latif R. The TSH receptor reveals itself. J Clin Invest 110 (2002) 161-164
2. Teng C.S., Rees S.B., Anderson J., and Hall R. Comparison of thyrotropin receptors in membranes prepared from fat and thyroid tissue. Biochem Biophys Res Commun 66 (1975) 836-841
3. Postiglione M.P., Parlato R., Rodriguez-Mallon A., Rosica A., Mithbaokar P., Maresca M., et al. Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci U S A 99 (2002) 15,462-15,467
4. Ma R., Latif R., and Davies T.F. TSH-independent induction of thyroid endoderm from embryonic stem cells by activin A. Endocrinology 150 (2009) 1970-1975
5. Abe E., Marians R.C., Yu W., Wu X.B., Ando T., Li Y., et al. TSH is a negative regulator of skeletal remodeling. Cell 115 (2003) 151-162
6. Rapoport B., and McLachlan S.M. The thyrotropin receptor in Graves' disease. Thyroid 17 (2007) 911-922
7. Ando T., Latif R., and Davies T.F. Thyrotropin receptor antibodies: new insights into their actions and clinical relevance. Best Pract Res Clin Endocrinol Metab 19 (2005) 33-52
8. Kaczur V., Puskas L.G., Nagy Z.U., Miled N., Rebai A., Juhasz F., et al. Cleavage of the human thyrotropin receptor by ADAM10 is regulated by thyrotropin. J Mol Recognit 20 (2007) 392-404
9. Atger M., Misrahi M., Young J., Jolivet A., Orgiazzi J., Schaison G., et al. Autoantibodies interacting with purified native thyrotropin receptor. Eur J Biochem 265 (1999) 1022-1031
10. Quellari M., Desroches A., Beau I., Beaudeux E., and Misrahi M. Role of cleavage and shedding in human thyrotropin receptor function and trafficking. Eur J Biochem 270 (2003) 3486-3497
11. Furszyfer J., Kurland L.T., McConahey W.M., and Elveback L.R. Graves' disease in Olmsted County, Minnesota, 1935 through 1967. Mayo Clin Proc 45 (1970) 636-644
12. Tunbridge W.M., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7 (1977) 481-493
13. Davies T.F., Ando T., Lin R.Y., Tomer Y., and Latif R. Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest 115 (2005) 1972-1983
14. Kendall-Taylor P., Dirmikis S.M., and Munro D.S. Long-acting thyroid stimulator and related factors. Proc R Soc Med 68 (1975) 252-253
15. Atger M., Misrahi M., Sar S., Le F.L., Dessen P., and Milgrom E. Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5′ non-coding regions. Mol Cell Endocrinol 111 (1995) 113-123
16. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212 (2006) 8-27
17. Saitoh O., and Nagayama Y. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology 147 (2006) 2417-2422
18. Chang X., Zheng P., and Liu Y. Homeostatic proliferation in the mice with germline FoxP3 mutation and its contribution to fatal autoimmunity. J Immunol 181 (2008) 2399-2406
19. Ban Y., Tozaki T., Tobe T., Ban Y., Jacobson E.M., Concepcion E.S., et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun 28 (2007) 201-207
20. Owen C.J., Eden J.A., Jennings C.E., Wilson V., Cheetham T.D., and Pearce S.H. Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J Mol Endocrinol 37 (2006) 97-104
21. Tomer Y., Menconi F., Davies T.F., Barbesino G., Rocchi R., Pinchera A., et al. Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun 29 (2007) 69-77
22. Ando T., Latif R., Daniel S., Eguchi K., and Davies T.F. Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinology 145 (2004) 5185-5193
23. Oda Y., Sanders J., Evans M., Kiddie A., Munkley A., James C., et al. Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies. Thyroid 10 (2000) 1051-1059
24. Ando T., Latif R., Pritsker A., Moran T., Nagayama Y., and Davies T.F. A monoclonal thyroid-stimulating antibody. J Clin Invest 110 (2002) 1667-1674
25. Sanders J., Jeffreys J., Depraetere H., Richards T., Evans M., Kiddie A., et al. Thyroid-stimulating monoclonal antibodies. Thyroid 12 (2002) 1043-1050
26. Costagliola S., Franssen J.D., Bonomi M., Urizar E., Willnich M., Bergmann A., et al. Generation of a mouse monoclonal TSH receptor antibody with stimulating activity. Biochem Biophys Res Commun 299 (2002) 891-896
27. Sanders J., Evans M., Premawardhana L.D., Depraetere H., Jeffreys J., Richards T., et al. Human monoclonal thyroid stimulating autoantibody. Lancet 362 (2003) 126-128
28. Iacovelli L., Capobianco L., Salvatore L., Sallese M., D'Ancona G.M., and De B.A. Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol Pharmacol 60 (2001) 924-933
29. Morshed S.A., Latif R., and Davies T.F. Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology 150 (2009) 519-529
30. Sanders J., Chirgadze D.Y., Sanders P., Baker S., Sullivan A., Bhardwaja A., et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17 (2007) 395-410
31. Sanders J., Miguel R.N., Bolton J., Bhardwaja A., Sanders P., Nakatake N., et al. Molecular interactions between the TSH receptor and a Thyroid-stimulating monoclonal autoantibody. Thyroid 17 (2007) 699-706
32. Michalek K, Latif R, Davies TF. 8 A.D. Thyrotropin receptor monoclonal antibody epitopes.
33. Jeffreys J., Depraetere H., Sanders J., Oda Y., Evans M., Kiddie A., et al. Characterization of the thyrotropin binding pocket. Thyroid 12 (2002) 1051-1061
34. Eckstein A.K., Plicht M., Lax H., Neuhauser M., Mann K., Lederbogen S., et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91 (2006) 3464-3470
35. Gerenova J., Buysschaert M., de Burbure C.Y., and Daumerie C. Prevalence of thyroid cancer in Graves' disease: a retrospective study of a cohort of 103 patients treated surgically. Eur J Intern Med 14 (2003) 321-325